Dir., President and Chief Scientific Officer at Regeneron Pharmaceuticals, Inc.
Dr. Yancopoulos joined Dr. Schleifer in 1989 as founding scientist of the Company, and together they built and have managed the Company since then. Dr. Yancopoulos is currently President and Chief Scientific Officer, and has served on the board since 2001. He received his M.D. and Ph.D. from Columbia University. Dr. Yancopoulos was the 11th most highly cited scientist in the world in the 1990s, and in 2004 he was elected to be a member of the National Academy of Sciences. Dr. Yancopoulos, together with key members of his team, is a principal inventor and/or developer of the six FDA-approved drugs the Company has developed, EYLEA (afliberce ...
Source: Regeneron Pharmaceuticals, Inc. on 04/23/2018
By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like George D. Yancopoulos M.D. Ph.D.. More specifically, you'll be able to:
Access over 200,000 executive and board member profiles.
Example: George D. Yancopoulos M.D. Ph.D.
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.